The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Skoropad V.Yu.

A.F. Tsyba Medical Radiological Scientific Center — branch of the National Medical Research Center of Radiology of the Ministry of Health of Russia

Mironova D.Yu.

Tsyb Medical Radiology Research Center

Kudryavtsev D.D.

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre

Smolenov E.I.

Tsyb Medical Radiology Research Center

Kolobaev I.V.

Tsyb Medical Radiology Research Center

Ivanov S.A.

Tsyb Medical Research Radiology Center;
People’s Friendship University of Russia

Kaprin A.D.

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center;
Peoples’ Friendship University of Russia named after Patrice Lumumba

Long-term clinical outcomes of patients with locally advanced gastric adenocarcinoma after two induction cycles of chemotherapy according to the FLOT regimen followed by chemoradiotherapy and radical surgery

Authors:

Skoropad V.Yu., Mironova D.Yu., Kudryavtsev D.D., Smolenov E.I., Kolobaev I.V., Ivanov S.A., Kaprin A.D.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2025;14(2): 5‑12

Read: 935 times


To cite this article:

Skoropad VYu, Mironova DYu, Kudryavtsev DD, Smolenov EI, Kolobaev IV, Ivanov SA, Kaprin AD. Long-term clinical outcomes of patients with locally advanced gastric adenocarcinoma after two induction cycles of chemotherapy according to the FLOT regimen followed by chemoradiotherapy and radical surgery. P.A. Herzen Journal of Oncology. 2025;14(2):5‑12. (In Russ.)
https://doi.org/10.17116/onkolog2025140215

Recommended articles:
The Russian consensus on the treatment of intrahepatic cholangiocarcinoma. Piro­gov Russian Journal of Surgery. 2024;(10):7-20
Diagnostic scales for acute appe­ndicitis in children. Piro­gov Russian Journal of Surgery. 2024;(10):80-87
Foreign body of the thyroid gland. Piro­gov Russian Journal of Surgery. 2024;(10):102-108
Heavy eye syndrome: clinical mani­festations, diagnosis and treatment. Russian Annals of Ophthalmology. 2024;(5):112-117
Giant peri­cranial sinus with exte­nsive occi­pital calvarium defect. Burdenko's Journal of Neurosurgery. 2024;(6):77-87

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. Malignant neoplasms in Russia in 2023 (morbidity and mortality). P.A. Herzen Moscow State Medical Institute — branch of the Federal State Budgetary Institution «NMHTS of Radiology» of the Ministry of Health of the Russian Federation; 2024. 276p. (In Russ.).
  2. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.  https://doi.org/10.3322/caac.21834
  3. Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, et al.; FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948-1957. https://doi.org/10.1016/S0140-6736(18)32557-1
  4. Skoropad VYu, Mironova DYu, Kolobaev IV, Ivanov SA, Kaprin AD. Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer. P.A. Herzen Journal of Oncology. 2024;13(2):15-20. (In Russ.). https://doi.org/10.17116/onkolog20241302115
  5. Zhu Y, Chen J, Sun X, Lou Y, Fang M, Zhou F, Zhang L, Xin Y. Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis. Front Oncol. 2023;13:1177557. https://doi.org/10.3389/fonc.2023.1177557
  6. Sisic L, Crnovrsanin N, Nienhueser H, Jung JO, Schiefer S, Haag GM, Bruckner T, Schneider M, Müller-Stich BP, Büchler MW, et al. Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective. Langenbecks Arch Surg. 2023;408(1):81.  https://doi.org/10.1007/s00423-023-02822-7
  7. Leong T, Smithers BM, Michael M, Haustermans K, Wong R, Gebski V, O’Connell RL, Zalcberg J, Boussioutas A, Findlay M, et al.; Australasian Gastro-Intestinal Trials Group, National Health and Medical Research Council Clinical Trials Centre, Trans-Tasman Radiation Oncology Group, European Organisation for Research and Treatment of Cancer, and Canadian Cancer Trials Group. Preoperative chemoradiotherapy for resectable gastric cancer. N Engl J Med. 2024;391(19):1810-1821. https://doi.org/10.1056/NEJMoa2405195
  8. Semenov NN, Izrailov RE, Semenov NE, Zhukova LG, Feoktistova PS, Matveichuk DA, Khat’kov IE. Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: a retrospective study. Journal of Modern Oncology. 2024;26(3):269-275. (In Russ.). https://doi.org/10.26442/18151434.2024.3.202981
  9. Skoropad VYu, Gulidov IA, Kudryavtsev DD, Titova LN, Smyk DI, Silant’eva NK, Agababyan TA, Zhavoronkova ES. Neoadjuvant chemoradiotherapy in the combined treatment of gastric cancer. Educational and methodical manual. Obninsk-Moscow; 2022. 30p. (In Russ.).
  10. Lukovic J, Moore AJ, Lee MT, Willis D, Ahmed S, Akra M, Hortobagyi E, Kron T, Lim Joon D, Liu A, et al. The feasibility of quality assurance in the TOPGEAR International Phase 3 Clinical Trial of neoadjuvant chemoradiation therapy for gastric cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG). Int J Radiat Oncol Biol Phys. 2023;117(5):1096-1106. https://doi.org/10.1016/j.ijrobp.2023.06.011
  11. Leong T, Smithers BM, Michael M, Haustermans K, Wong R, Gebski V, O’Connell RL, Zalcberg J, Boussioutas A, Findlay M, et al.; Australasian Gastro-Intestinal Trials Group, National Health and Medical Research Council Clinical Trials Centre, Trans-Tasman Radiation Oncology Group, European Organisation for Research and Treatment of Cancer, and Canadian Cancer Trials Group. Preoperative chemoradiotherapy for resectable gastric cancer. N Engl J Med. 2024;391(19):1810-1821. https://doi.org/10.1056/NEJMoa2405195
  12. Anokhin AYu, Kononets PV, Kanner DYu, Stroyakovskii DL, Shveikin AO, Kalinin AE, Kirsanov VYu, Tyulyandina AS. Efficacy of total neoadjuvant chemotherapy in the FLOT regimen in patients with locally advanced gastric and gastroesophageal junction: results of a phase II study. Surgery and Oncology. 2024;14(1):62-71. (In Russ.). https://doi.org/10.17650/2949-5857-2024-14-1-62-71
  13. Drake JA, Stiles ZE, Tsao MW, Deneve JL, Glazer ES, Yakoub D, Grothey A, Somer BG, Dickson PV. Analysis of the survival impact of postoperative chemotherapy after preoperative chemotherapy and resection for gastric cancer. Ann Surg Oncol. 2021;28(3):1417-1427. https://doi.org/10.1245/s10434-020-09045-w
  14. Blank S, Stange A, Sisic L, Roth W, Grenacher L, Sterzing F, Burian M, Jäger D, Büchler M, Ott K. Preoperative therapy of esophagogastric cancer: the problem of nonresponding patients. Langenbecks Arch Surg. 2013;398(2):211-220.  https://doi.org/10.1007/s00423-012-1034-5
  15. Cho H, Nakamura J, Asaumi Y, Yabusaki H, Sakon M, Takasu N, Kobayashi T, Aoki T, Shiraishi O, Kishimoto H, et al. Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature. Ann Surg Oncol. 2015;22(3):787-792.  https://doi.org/10.1245/s10434-014-4084-9
  16. Tomasello G, Petrelli F, Ghidini M, Pezzica E, Passalacqua R, Steccanella F, Turati L, Sgroi G, Barni S. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: a meta-analysis of 17 published studies. Eur J Surg Oncol. 2017;43(9):1607-1616. https://doi.org/10.1016/j.ejso.2017.03.001
  17. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Gastric Cancer. Version 4.2024. 2024. NCCN.org. 
  18. Slagter AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, van Grieken NCT, Sikorska K, Cats A, Muller-Timmermans P, Hulshof MCCM, Boot H, et al. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. BMC Cancer. 2018;18(1):877.  https://doi.org/10.1186/s12885-018-4770-2
  19. Karabina EV. Individualization of adjuvant therapy: who can I refuse? Practical Oncology. 2023;24(3):319-325. (In Russ.). https://doi.org/10.31917/2404319
  20. Liu X, Ma B, Zhao L. Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma. Front Oncol. 2024;14:1342162. https://doi.org/10.3389/fonc.2024.1342162
  21. Janjigian YY, Van Cutsem E, Muro K, Wainberg Z, Al-Batran SE, Hyung WJ, Molena D, Marcovitz M, Ruscica D, Robbins SH, et al. MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer. Future Oncol. 2022;18(20):2465-2473. https://doi.org/10.2217/fon-2022-0093
  22. Liu X, Jin J, Cai H, Huang H, Zhao G, Zhou Y, Wu J, Du C, Long Z, Fang Y, et al. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT. BMC Cancer. 2019;19(1):606.  https://doi.org/10.1186/s12885-019-5728-8

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.